SNC162

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2016
01219962016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND AND PURPOSE δ Opioid receptor agonists are being developed as potential treatments for depression and alcohol use… (More)
Is this relevant?
2010
2010
Mu-opioid receptor agonists such as fentanyl are effective analgesics, but their clinical use is limited by untoward effects… (More)
Is this relevant?
2008
2008
In the present study, whole-cell patch-clamp technique was used to observe the effects of SNC162, a selective agonist of δ-opioid… (More)
Is this relevant?
2004
2004
The diarylpiperazine delta-opioid agonist SNC80 [(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3… (More)
Is this relevant?
2002
2002
The majority of reports assessing opioid drug discrimination learning (DDL) have concentrated on characterizing the stimulus… (More)
Is this relevant?
2001
2001
Tolerance and dependence after acute or chronic administration of the selective delta-opioid agonist SNC80 were assessed in… (More)
Is this relevant?
2001
2001
The effects of SNC80 and other structurally related delta-opioid receptor agonists were assessed under conditions of chemically… (More)
Is this relevant?
1999
1999
Five rhesus monkeys were trained to discriminate the nonpeptidic, delta-opioid agonist SNC80 (0.32 mg/kg i.m.) from saline by… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1999
1999
Five rhesus monkeys were trained to discriminate the nonpeptidic, d-opioid agonist SNC80 (0.32 mg/kg i.m.) from saline by using a… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1996
1996
The racemic compound (+/-)-BW373U86 ¿(+/-)-4-((alpha R*)- alpha-((2S*,5R*)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxy- benzyl… (More)
Is this relevant?